Multiwalled carbon nanotube–doxorubicin supramolecular complexes for cancer therapeutics (original) (raw)
* Corresponding authors
a Nanomedicine Laboratory, Centre for Drug Delivery, The School of Pharmacy, University of London, 29-39 Brunswick Square, London, UK
E-mail: kostas.kostarelos@pharmacy.ac.uk
Fax: +44 20 7757 5942
Tel: +44 20 77535861
b Dipartimento di Scienze Farmaceutiche, Università di Trieste, Trieste, Italy
c Institut de Biology Molèculaire et Cellulaire, UP R9021 CNRS, Immunologie et Chimie Thèrapeutiques, Strasbourg, France
Abstract
Multiwalled carbon nanotube aqueous dispersions using block copolymers are able to form supramolecular complexes with the aromatic chromophore and anticancer agent doxorubicin_via_ π–π stacking and enhance its cytotoxic activity.
- This article is part of the themed collections:ChemComm contributions to the United Nations Sustainable Development Goals and ChemComm 60th Anniversary Historic Papers from the United Kingdom
You have access to this article
Please wait while we load your content... Something went wrong. Try again?
Article information
DOI
https://doi.org/10.1039/B712350G
Article type
Communication
Submitted
10 Aug 2007
Accepted
05 Nov 2007
First published
14 Nov 2007
Download Citation
Chem. Commun., 2008, 459-461
Permissions
Multiwalled carbon nanotube–doxorubicin supramolecular complexes for cancer therapeutics
H. Ali-Boucetta, K. T. Al-Jamal, D. McCarthy, M. Prato, A. Bianco and K. Kostarelos,Chem. Commun., 2008, 459DOI: 10.1039/B712350G
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.